Investigation on Safety and Efficacy of Soybean Fermented Extract (MBS217) in Treating Patients With NAFLD

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
Investigators aimed to investigate the efficacy and safety of fermented soybean extract (MBS-217) in treating participants with Non-alcoholic fatty liver disease (NAFLD) in this study.
Epistemonikos ID: 0d3c0f01909caede9ba6bfbd9fe749e10424c309
First added on: Feb 19, 2024